CordenPharma, a global CDMO in the manufacturing of drug substance (APIs) complex modalities (such as peptides, oligos and lipids) and injectable drug products, and GENEPEP, a French CRO specializing in the design, chemical synthesis, and optimization of peptides, have celebrated one year of their collaboration.
DENVER, Feb. 14, 2024 /PRNewswire/ -- Leading national renewable energy provider Pivot Energy is proud to announce that CordenPharma, a global leader in the contract development and manufacturing of pharmaceuticals, has taken a significant step towards sustainable energy practices through an off-site net metering agreement.
LONDON, Oct 19 (Reuters) - Eli Lilly (LLY.N) has hired Switzerland-based contract drugmaker CordenPharma to produce the active ingredient in its diabetes drug Mounjaro, a source familiar with the matter told Reuters on Thursday.
BASEL, Switzerland, July 26, 2023 /PRNewswire/ -- CordenPharma, a leading pharmaceutical Contract Development and Manufacturing Organization (CDMO), has created a new Technology & Science Advisory Board (TSAB) with eight world-class experts from academia and industry, who will provide strategic guidance and scientific expertise to drive forward the company's continued growth and innovation.
CordenPharma Announces Entry into Oligonucleotide API Manufacturing
Munich, Plankstadt and Berlin, March 30, 2023 – Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), Wacker Chemie AG and CordenPharma International GmbH have launched a project to accelerate the development of RNA-based drugs. The aim is to develop a new generation of lipid nanoparticles (LNPs), which are a key component of RNA-based pharmaceuticals. Based on these formulations, a machine learning algorithm is to be trained that automatically identifies the best constituents for new RNA formulations – as yet a particularly time-consuming and costly development stage. The three-year project will start on April 1, 2023 and is receiving funding of some €1.4 million from the German Federal Ministry for Economic Affairs and Energy.
Lipid NanoParticles (LNPs) have emerged as promising non-viral nanocarriers to deliver a variety of therapeutics. Specifically, they are considered ideal delivery systems for DNA, mRNA and synthetic RNAs (siRNA, microRNA, saRNA) due to their outstanding biocompatibility, biodegradability, and entrapment efficiency. Currently in the spotlight as core components of the COVID-19 mRNA vaccines, LNPs play a key role in the development of novel xRNA therapeutics under preclinical and clinical investigation as the main delivery platform of choice.
CordenPharma has signed a multi-year agreement starting in 2023 for the contract manufacturing of a large-volume peptide at its CordenPharma Colorado facility.
CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of innovative Active Pharmaceutical Ingredients (APIs), Lipid Excipients, and Drug Products, has joined the Science Based Targets initiative (SBTi) to actively drive down global emissions across the company.
The ideal CDMO partner is an extension of the customer’s team, in that they are actually in fact partners working on the project together. A CDMO shouldn’t be a transactional order taker. There needs to be two-way transparent communication between both parties, identifying risks and solving problems together. Issues will arise, as they always do, but it is how they are handled that is most important. An experienced CDMO partner is also very service-oriented, possibly offering an integrated approach with multiple complementary services, so the customer does not have to manage multiple teams around the globe. For example, expert CDMOs bring seamless API to Drug Product manufacturing and packaging services, which can be performed between multiple sites. What makes a truly integrated service is when experienced project teams work together to communicate with each other frequently, foreseeing issues and taking care of supply chain logistics, materials, production windows, timeline management, shipping, customs, etc., all under the guidance of a Global Program Manager with oversight of all teams, services and sites.